Cargando…
Recent Developments in Delivery of MicroRNAs Utilizing Nanosystems for Metabolic Syndrome Therapy
Metabolic syndrome (MetS) is a set of complex, chronic inflammatory conditions that are characterized by central obesity and associated with an increased risk of cardiovascular diseases. In recent years, microRNAs (miRNAs) have become an important type of endocrine factors, which play crucial roles...
Autores principales: | Li, Tong, Zhu, Liye, Zhu, Longjiao, Wang, Pengjie, Xu, Wentao, Huang, Jiaqiang |
---|---|
Formato: | Online Artículo Texto |
Lenguaje: | English |
Publicado: |
MDPI
2021
|
Materias: | |
Acceso en línea: | https://www.ncbi.nlm.nih.gov/pmc/articles/PMC8346175/ https://www.ncbi.nlm.nih.gov/pubmed/34360621 http://dx.doi.org/10.3390/ijms22157855 |
Ejemplares similares
-
Micro/Nanosystems for Magnetic Targeted Delivery of Bioagents
por: Garello, Francesca, et al.
Publicado: (2022) -
Recent Advances in Nanosystems and Strategies for Vaginal Delivery of Antimicrobials
por: Chindamo, Giulia, et al.
Publicado: (2021) -
Dietary Selenium Regulates microRNAs in Metabolic Disease: Recent Progress
por: Huang, Xin, et al.
Publicado: (2021) -
Advanced Drug Delivery Micro- and Nanosystems for Cardiovascular Diseases
por: Iravani, Siavash, et al.
Publicado: (2022) -
Smart and Functionalized Development of Nucleic Acid‐Based Hydrogels: Assembly Strategies, Recent Advances, and Challenges
por: Zhang, Yangzi, et al.
Publicado: (2021)